We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
MedAdvisor Limited is a health information services business based in Australia. MedAdvisor shares (MDR) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. MedAdvisor has a trailing 12-month revenue of around $38.8 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.23 - $0.45 |
|---|---|
| 50-day moving average | $0.3219 |
| 200-day moving average | $0.3205 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.044 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.31
| 1 week (2021-09-16) | 1.64% |
|---|---|
| 1 month (2021-08-26) | -10.14% |
| 3 months (2021-06-25) | 3.33% |
| 6 months (2021-03-26) | -11.43% |
| 1 year (2020-09-25) | -31.11% |
|---|---|
| 2 years (2019-09-26) | -86.25% |
| 3 years (2018-09-26) | -84.18% |
| 5 years (2016-09-26) | -84.94% |
| Revenue TTM | $38.8 million |
|---|---|
| Gross profit TTM | $-2,136,967 |
| Return on assets TTM | -20.6% |
| Return on equity TTM | -43.64% |
| Profit margin | -35.98% |
| Book value | 0.128 |
| Market capitalisation | $117 million |
TTM: trailing 12 months
We're not expecting MedAdvisor to pay a dividend over the next 12 months.
MedAdvisor 's shares were split on a 1:7 basis on 19 November 2019. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your MedAdvisor shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for MedAdvisor shares which in turn could have impacted MedAdvisor 's share price.
Over the last 12 months, MedAdvisor 's shares have ranged in value from as little as $0.23 up to $0.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while MedAdvisor 's is 0.1043. This would suggest that MedAdvisor 's shares are less volatile than average (for this exchange).
MedAdvisor Limited, together with its subsidiaries, develops and delivers software for personal medication management in Australia, the United States, the United Kingdom, and Asia. The company provides MedAdvisor, a medication and adherence platform that focuses on improving health outcomes by connecting health professionals with their patients using technology and enhancing medication adherence through health programs using mobile and web apps. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
We look at some of the biggest and best performing iron ore stocks in Australia.
Shares in the major banks have risen more than 50% in the last 12 months.
Steps to owning and managing China Evergrande Group shares from Australia.
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
